| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |